Evidence map›Paper›PMID 26460301›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Precision Oncology Framework for Investigation of Exercise As Treatment for Cancer.

Lee W Jones

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Variability in resistance training trajectories of breast cancer patients undergoing therapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Exercise therapy in cancer prevention and treatment.Nature reviews. Clinical oncology · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Pan-Cancer Analysis of Postdiagnosis Exercise and Mortality.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lee W JonesMemorial Sloan Kettering Cancer Center, New York, NY jonesl3@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'R01CA179992 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONES, LEE W · 2013 to 2019
$3.1M
Aerobic Training During or After Adjuvant Therapy: A Randomized TrialR01CA164751 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONES, LEE W · 2012 to 2019
$3.1M
Randomized Trial of Optimal Type of Aerobic Training in Breast CancerR01CA142566 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONES, LEE W · 2010 to 2017
$2.7M
Phase III Trial of Exercise Training in Postsurgical Lung CancerR01CA138624 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONES, LEE W · 2009 to 2013
$2.1M
Phase II Trial of Aerobic Training in Metastatic Breast CancerR21CA143254 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONES, LEE W · 2010 to 2012
$536k
NCI NIH HHS CA138624NCI NIH HHS CA142566NCI NIH HHS CA143254NCI NIH HHS CA164751NCI NIH HHS CA179992NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA138624NCI NIH HHS R01 CA142566NCI NIH HHS R01 CA164751NCI NIH HHS R01 CA179992NCI NIH HHS R21 CA143254
6 · The paper itself

Abstract

Promising discovery (epidemiologic) data have led to the provocative hypothesis that exercise treatment may improve cancer outcomes, fueling calls for the need for large phase III trials to definitively test this question. Emerging epidemiologic data suggest that the potential efficacy of exercise differs on the basis of tumor subtype. The heterogeneity in response creates the strong hypothesis that a precision oncology approach is required to optimize the benefit and safety of exercise as a candidate antitumor strategy. This commentary has presented one potential translational framework that may facilitate these efforts. It is hoped that the concepts described here will provide the platform for constructive dialogue and interdisciplinary collaboration to optimize the therapeutic promise of exercise treatment.

Indexed as

ExercisePrecision MedicineClinical Trials as TopicHumansMedical OncologyNeoplasms

Identifiers

PMID26460301
PMCPMC4979240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.